Nimodipine

This classification denotes a calcium channel blocker with the molecular formula C21H26N2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 57WA9QZ5WH, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester but generally known as nimodipine, which bears US NIH Compound Identifier 4497. European Medicines Agency schedules Nimodipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09297MIG. The term NIMODIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules nimodipine in its Anatomical Therapeutic Chemical (ATC) Classification. NIMODIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nimodipine under HS 29333999 and SITC 51574. As of Q4 2014, NIMODIPINE remains the US FDA Preferred Term for this commodity. Nimodipine bears US NLM identifiers UMLS ID C0678207 and NCI Concept Code C692. SMILES: O(C(=O)C1=C(NC(=C(C1c1cc([N](=O)O)ccc1)C(=O)OCCOC)C)C)C(C)C.